41 results on '"Dobard, Charles"'
Search Results
2. Author Correction: Ultra-long-acting in-situ forming implants with cabotegravir protect female macaques against rectal SHIV infection
3. Pharmacokinetic Study of Islatravir and Etonogestrel Implants in Macaques
4. Weekly Oral Tenofovir Alafenamide Protects Macaques from Vaginal and Rectal Simian HIV Infection.
5. Efficacy of Vaginally Administered Gel Containing Emtricitabine and Tenofovir Against Repeated Rectal Simian Human Immunodeficiency Virus Exposures in Macaques
6. Single dose topical inserts containing tenofovir alafenamide fumarate and elvitegravir provide pre- and post-exposure protection against vaginal SHIV infection in macaques
7. Protection Against Rectal Chimeric Simian/Human Immunodeficiency Virus Transmission in Macaques by Rectal-Specific Gel Formulations of Maraviroc and Tenofovir
8. Topical tenofovir protects against vaginal simian HIV infection in macaques coinfected with Chlamydia trachomatis and Trichomonas vaginalis
9. Pharmacokinetics of vaginally applied integrase inhibitors in macaques
10. Assessment of penile erection methods in rhesus macaques to model pharmacokinetics of antiretroviral drugs and penile infection with simian immunodeficiency virus
11. Development, Characterization and In Vivo Pharmacokinetic Assessment of Rectal Suppositories Containing Combination Antiretroviral Drugs for HIV Prevention
12. Tenofovir Alafenamide for HIV Prevention: Review of the Proceedings from the Gates Foundation Long-Acting TAF Product Development Meeting
13. SHIV SUSCEPTIBILITY CHANGES DURING THE MENSTRUAL CYCLE OF PIGTAIL MACAQUES: ABSTRACT #34
14. Development and optimization of a non-enzymatic method of leukocyte isolation from macaque tissues
15. The effect of depot medroxyprogesterone acetate on tenofovir alafenamide in rhesus macaques
16. ASSESSING DRUG RESISTANCE EMERGENCE IN A MACAQUE MODEL OF ANTIRETROVIRAL PRE-EXPOSURE PROPHYLAXIS (PREP): Abstract #54
17. Long-Acting Cabotegravir Protects Macaques Against Repeated Penile Simian-Human Immunodeficiency Virus Exposures
18. Formulation of a microbicide gel with integrase inhibitor and evaluation of safety in female pig-tailed macaques: 007
19. Development of a repeat-exposure penile SHIV infection model in macaques to evaluate biomedical preventions against HIV
20. Short Communication: Practical Experience with Analysis and Design of Repeat Low-Dose SHIVSF162P3 Exposure Studies in Female Pigtail Macaques with Varying Susceptibility During Menstrual Cycling
21. Efficacy of topical tenofovir against transmission of a tenofovir-resistant SHIV in macaques
22. Repeated Vaginal SHIV Challenges in Macaques Receiving Oral or Topical Preexposure Prophylaxis Induce Virus-Specific T-Cell Responses
23. VAGINAL PrEP EFFICACY OF BIODEGRADABLE ISLATRAVIR IMPLANTS IN MACAQUES.
24. Short Communication: Viremic Control Is Independent of Repeated Low-Dose SHIVSF162p3Exposures
25. Rectal Specific Gels Containing Maraviroc and/or Tenofovir Protect against Rectal SHIV Transmission in a Macaque Model
26. Postexposure Protection of Macaques from Vaginal SHIV Infection by Topical Integrase Inhibitors
27. Short Communication: Practical Experience with Analysis and Design of Repeat Low-Dose SHIVSF162P3 Exposure Studies in Female Pigtail Macaques with Varying Susceptibility During Menstrual Cycling.
28. Durable Protection from Vaginal Simian-Human Immunodeficiency Virus Infection in Macaques by Tenofovir Gel and Its Relationship to Drug Levels in Tissue
29. Topical tenofovir protects against vaginal simian HIV infection in macaques coinfected with Chlamydia trachomatisand Trichomonas vaginalis
30. Protection against Rectal Transmission of an Emtricitabine-Resistant Simian/Human Immunodeficiency Virus SHIV162p3 M184V Mutant by Intermittent Prophylaxis with Truvada
31. High Susceptibility to Repeated, Low-Dose, Vaginal SHIV Exposure Late in the Luteal Phase of the Menstrual Cycle of Pigtail Macaques
32. Generation and mucosal transmissibility of emtricitabine- and tenofovir-resistant SHIV162P3 mutants in macaques
33. Role of Human Immunodeficiency Virus Type 1 Integrase in Uncoating of the Viral Core
34. Complete Protection from Repeated Vaginal Simian-Human Immunodeficiency Virus Exposures in Macaques by a Topical Gel Containing Tenofovir Alone or with Emtricitabine
35. Molecular Mechanisms by Which Human Immunodeficiency Virus Type 1 Integrase Stimulates the Early Steps of Reverse Transcription
36. Short Communication: Viremic Control Is Independent of Repeated Low-Dose SHIVSF162p3 Exposures.
37. Requirement for Integrase during Reverse Transcription of Human Immunodeficiency Virus Type 1 and the Effect of Cysteine Mutations of Integrase on Its Interactions with Reverse Transcriptase
38. Requirement for Integrase during Reverse Transcription of Human Immunodeficiency Virus Type 1 and the Effect of Cysteine Mutations of Integrase on Its Interactions with Reverse Transcriptase.
39. Repeated Vaginal SHIV Challenges in Macaques Receiving Oral or Topical Preexposure Prophylaxis Induce Virus-Specific T-Cell Responses.
40. Protection against rectal transmission of an emtricitabine-resistant simian/human immunodeficiency virus SHIV162p3M184V mutant by intermittent prophylaxis with Truvada.
41. High susceptibility to repeated, low-dose, vaginal SHIV exposure late in the luteal phase of the menstrual cycle of pigtail macaques.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.